Aging Fit Substack: Learn More

Repeat life science entrepreneur Tom Weldon is now taking on aging. He is commercializing a compound to extend health span developed at a prominent institution. Composed of substances generally considered as safe by the FDA, the formula has shown impressive results in mice and, to date, in one human, Tom himself. Intriguing chat with a dynamic founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

• Sal Daher Introduces Tom Weldon
• What Problem Rejuvant Addresses
• "... Then the first time the combination is not additive, take it out. That's a process that would probably take a year or two, but it ensures that you'll have an optimal result. Or, you can buy Rejuvant, because we did all that work already..."
• "... if you decide that you'd like to try Rejuvant and you go on subscription, we give you a free DNA methylation test at time zero and then we give you another one after six months, which is included in the cost ... They're different and they have different algorithms. All of them except two that I'm aware of, one of which is what we provide, requires your current chronologic age as an input..."
• "... It was actually discovered by Steve Horvath and he developed the first biologic clock ... Your DNA is damaged every second that you're alive. Prior to puberty, your body does an exceptional job of repairing all of that. However, after that, it starts to decline..."
• "... Is there any evidence that repair is actually at work? How do we know that it's not just removing the methyl molecule from the DNA, and you have damaged the DNA that's just not methylated?..."
• "... How long have you been on Rejuvant?..."
• How Tom Became an Entrepreneur
• "... This company had this trajectory and now it's just gone Chapter 7 recently. That is the tough side of these life science technology companies because the technology moves so fast..."
• "... very difficult space. What I have seen in the medical device space, these 510k pathway devices where there is an existing predicate device, and then you can design something which is, no worse and perhaps much better than the predicate device..."
• Advice to the Audience

Topics: biotech, discovering entrepreneurship, founding story